PPP2R1A expression was significantly associated with lung adenocarcinoma stage; advanced-stage (III-IV) LUAD patients exhibited significantly higher PPP2R1A expression compared to early-stage (I-II) cases (Figure 3E). This evidence concerns the gene PPP2R1A and lung adenocarcinoma.